Imaging macrophage distribution and density in mammary tumors and lung metastases using fluorine‐19 MRI cell tracking. Issue 3 (12th January 2018)

• Record Type: Journal Article
• Authors: Makela, Ashley V.; Foster, Paula J.
• Is Part Of: Magnetic resonance in medicine. Volume 80:Issue 3(2018)
• Page Start: 1138
• Page End: 1147
• Publication Date: 2018-01-12
• Subjects: 19‐fluorine (19F) -- breast cancer -- metastasis‐associated macrophage (MAM) -- MRI cell tracking -- tumor‐associated macrophage (TAM); Nuclear magnetic resonance -- Periodicals; Electron paramagnetic resonance -- Periodicals; 616.07548
• DOI: 10.1002/mrm.27081
• Languages: English
• ISSNs: 0740-3194

Abstract

Abstract : Purpose: The presence of tumor‐associated macrophages (TAMs) correlates with breast cancer progression and metastatic spread. Metastasis‐associated macrophages (MAMs) are also recruited to distant sites, where they support metastatic growth. In this study, we demonstrate that in vivo fluorine‐19 ( 19 F)‐based MRI cell tracking can evaluate the density and distribution of macrophages within murine breast cancer tumors and associated metastases. Methods: Three murine breast cancer cell lines with different metastatic potentials (4T1, 168FARN, and 67NR) were implanted into the mammary fat pad in mice. In vivo whole body 19 F MRI was performed on tumor‐bearing mice 24 hours post‐intravenous injection of a perfluorocarbon (PFC) agent, which was taken up by macrophages in situ. Results: TAMs were detected mainly in the periphery of primary tumors, and higher numbers of TAMs were detected in the more aggressive 4T1 tumors. Tumors had significantly greater 19 F spins/mm 3 when they were smaller, suggesting more TAM infiltration in early‐stage tumors. 19 F signal was observed within lung metastases in mice with 4T1 tumors, and fluorescence microscopy confirmed the presence of PFC‐positive macrophages. Conclusion: This study shows for the first time proof of the ability to use MRI cell tracking to visualize MAMs in the lungs. The ability to detect and monitor the number of TAMs in individual tumors with 19 F MRI would allow for identification of breast tumors with heavy infiltration of TAMs and could be used as a biomarker for decisions about how to best treat these patients as well as for monitoring responses to therapy. Magn Reson Med 80:1138–1147, 2018. © 2018 International Society for Magnetic Resonance in Medicine.